§ Mrs. LawrenceTo ask the Secretary of State for Health how many UK-resident patients over the age of 16 are being treated with rcFVIII. [22325]
§ Yvette CooperThe latest information from the United Kingdom Haemophilia Centre Doctors Organisation shows that 43 per cent. of patients aged 20 and over in the United Kingdom are receiving recombinant clotting factors.
All health authorities and national health service trusts in England have been asked to provide recombinant (synthetic) clotting factors for new haemophilia patients and children under 16. We are giving careful consideration to the case for providing recombinant clotting factors for all haemophilia patients in England.